Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 2007-2019

  Agustian, Putri A ^a   Schiffer, Mario ^a   Gwinner, Wilfried ^a   Schäfer, Irini ^a   Theophile, Katharina ^a   Modde, Friedrich ^a   Bockmeyer, Clemens L ^a   Traeder, Jana ^a   Lehmann, Ulrich ^a   Großhennig, Anika ^a   Kreipe, Hans H ^a   Bröcker, Verena ^a   Becker, Jan Ulrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN KINASE B; RAPAMYCIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TACROLIMUS; TYROSINE; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; AGED; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DIAGNOSTIC PROCEDURE; FEMALE; GLOMERULOPATHY; GLOMERULUS; GLOMERULUS FILTRATION; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PARACRINE SIGNALING; PODOCYTE; PODOCYTOPENIA; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSPLANT GLOMERULOPATHY;

EID: 79959270641     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.01.042     Document Type: Article

References (91)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004, 4:378-383 (Pubitemid 38282293)
2. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al.: The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713-723 (Pubitemid 29082898)
3. Cosio FG, Gloor JM, Sethi S, Stegall MD: Transplant glomerulopathy. Am J Transplant 2008, 8:492-496 (Pubitemid 351287536)
4. Colvin RB: Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007, 18:1046-1056
5. Nankivell BJ, Chapman JR: Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006, 81:643-654
6. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007, 7:518-526 (Pubitemid 46376465)
7. Li C, Yang CW: The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol 2009, 5:513-519
8. Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, Degoey S, Griffin MD, Larson TS, Cosio FG: Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007, 7:2124-2132 (Pubitemid 47247042)
9. Wavamunno MD, O'Connell PJ, Vitalone M, Fung CL, Allen RD, Chapman JR, Nankivell BJ: Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007, 7:2757-2768 (Pubitemid 350045771)
10. Monga G, Mazzucco G, Novara R, Reale L: Intertubular capillary changes in kidney allografts: an ultrastructural study in patients with transplant glomerulopathy. Ultrastruct Pathol 1990, 14:201-209 (Pubitemid 20173791)
11. Ivanyi B, Fahmy H, Brown H, Szenohradszky P, Halloran PF, Solez K: Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study. Hum Pathol 2000, 31:1129-1138
12. Sis B, Campbell PM, Mueller T, Hunter C, Cockfield SM, Cruz J, Meng C, Wishart D, Solez K, Halloran PF: Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007, 7:1743-1752 (Pubitemid 46905427)
13. Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, Watschinger B, Kerjaschki D, Exner M: Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002, 13:2371-2380 (Pubitemid 34925248)
14. Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009, 9:2520-2531
15. Perkowska-Ptasinska A, Ciszek M, Chmura A, Galazka Z, Paczek L, Durlik M: Transplant glomerulopathy: clinical and pathological correlations. Transplant Proc 2009, 41:141-149
16. Patrakka J, Tryggvason K: New insights into the role of podocytes in proteinuria. Nat Rev Nephrol 2009, 5:463-468
17. Fries JW, Sandstrom DJ, Meyer TW, Rennke HG: Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 1989, 60:205-218 (Pubitemid 19072404)
18. Kriz W, Kretzler M, Nagata M, Provoost AP, Shirato I, Uiker S, Sakai T, Lemley KV: A frequent pathway to glomerulosclerosis: deterioration of tuft architecture-podocyte damage-segmental sclerosis. Kidney Blood Press Res 1996, 19:245-253 (Pubitemid 26395311)
19. Chen CA, Hwang JC, Guh JY, Chang JM, Lai YH, Chen HC: Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. J Lab Clin Med 2006, 147:74-82
20. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD: Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002, 61:1475-1485 (Pubitemid 34304509)
21. Wang G, Lai FM, Kwan BC, Lai KB, Chow KM, Li PK, Szeto CC: Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009, 22:300-306
22. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997, 99:342-348 (Pubitemid 27053474)
23. Steffes MW, Schmidt D, McCrery R, Basgen JM: Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001, 59:2104-2113 (Pubitemid 32467602)
24. Petermann AT, Krofft R, Blonski M, Hiromura K, Vaughn M, Pichler R, Griffin S, Wada T, Pippin J, Durvasula R, Shankland SJ: Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int 2003, 64:1222-1231 (Pubitemid 37153787)
25. Pippin J, Kumar V, Stein A, Jablonski P, Shankland SJ, Davis CL: The contribution of podocytes to chronic allograft nephropathy. Nephron Exp Nephrol 2009, 111:e1-e10
26. Nagata M, Nakayama K, Terada Y, Hoshi S, Watanabe T: Cell cycle regulation and differentiation in the human podocyte lineage. Am J Pathol 1998, 153:1511-1520 (Pubitemid 28509908)
27. Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E: Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 2003, 14:2833-2842 (Pubitemid 37305646)
28. Nakamura T, Nawa K, Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984, 122:1450-1459 (Pubitemid 14073577)
29. Russell WE, McGowan JA, Bucher NL: Partial characterization of a hepatocyte growth factor from rat platelets. J Cell Physiol 1984, 119:183-192 (Pubitemid 14112405)
30. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T: Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987, 224:311-316
31. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Gohda E, Daikuhara Y, Kitamura N: Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989, 163:967-973 (Pubitemid 19236944)
32. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443 (Pubitemid 19277521)
33. Ishibashi K, Sasaki S, Sakamoto H, Nakamura Y, Hata T, Nakamura T, Marumo F: Hepatocyte growth factor is a paracrine factor for renal epithelial cells: stimulation of DNA synthesis and NA, K-ATPase activity. Biochem Biophys Res Commun 1992, 182:960-965
34. Matsumoto K, Nakamura T: Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001, 59: 2023-2038 (Pubitemid 32467594)
35. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993, 265:F61-F69 (Pubitemid 23221552)
36. Longati P, Albero D, Comoglio PM: Hepatocyte growth factor is a pleiotropic factor protecting epithelial cells from apoptosis. Cell Death Differ 1996, 3:23-28 (Pubitemid 26072527)
37. Yamasaki N, Nagano T, Mori-Kudo I, Tsuchida A, Kawamura T, Seki H, Taiji M, Noguchi H: Hepatocyte growth factor protects functional and histological disorders of HgCl(2)-induced acute renal failure mice. Nephron 2002, 90:195-205
38. Yang J, Liu Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002, 13:96-107 (Pubitemid 34042016)
39. Ma PC, Maulik G, Christensen J, Salgia R: c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev 2003, 22:309-325 (Pubitemid 36791889)
40. Fornoni A, Li H, Foschi A, Striker GE, Striker LJ: Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol 2001, 158:275-280 (Pubitemid 32096493)
41. Liu Y: Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 2004, 287:F7-F16
42. Khwaja A, Lehmann K, Marte BM, Downward J: phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J Biol Chem 1998, 273:18793-18801 (Pubitemid 28366264)
43. Besser D, Bardelli A, Didichenko S, Thelen M, Comoglio PM, Ponzetto C, Nagamine Y: Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. Oncogene 1997, 14:705-711 (Pubitemid 27095862)
44. Manning BD, Cantley LC: AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274 (Pubitemid 46962095)
45. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001, 108:807-816 (Pubitemid 32880291)
46. Dai C, Saleem MA, Holzman LB, Mathieson P, Liu Y: Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int 2010, 77:962-973
47. Sanden SK, Wiggins JE, Goyal M, Riggs LK, Wiggins RC: Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol 2003, 14:2484-2493 (Pubitemid 37169334)
48. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria: an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003, 3:708-714 (Pubitemid 36745243)
49. Racusen LC, Halloran PF, Solez K: Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 2004, 4:1562-1566
50. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M: Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753-760 (Pubitemid 351347767)
51. Cen L, Arnoczky KJ, Hsieh FC, Lin HJ, Qualman SJ, Yu S, Xiang H, Lin J: Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma. Mod Pathol 2007, 20:936-946 (Pubitemid 47267820)
52. Benvenuti S, Comoglio PM: The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 2007, 213:316-325 (Pubitemid 47509708)
53. Eder JP, Vande Woude GF, Boerner SA, LoRusso PM: Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 2009, 15:2207-2214
54. Mundel P, Kriz W: Cell culture of podocytes. Exp Nephrol 1996, 4:263-266 (Pubitemid 26342894)
55. Deveraux QL, Takahashi R, Salvesen GS, Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388:300-304 (Pubitemid 27317977)
56. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998, 17:2215-2223 (Pubitemid 28171907)
57. World Medical Association: WMA Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Ferney-Voltaire, France: World Medical Association, 2008. Available at http://www.wma.net/en/ 30publications/10policies/b3/
58. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases: insights from animal models. Kidney Int 2005, 67:404-419 (Pubitemid 40139832)
59. Kriz W: The pathogenesis of 'classic' focal segmental glomerulosclerosis: lessons from rat models. Nephrol Dial Transplant 2003, 18(Suppl 6):vi39 -vi44
60. Osterby R, Nyberg G, Karlberg I, Svalander C: Glomerular volume in kidneys transplanted into diabetic and non-diabetic patients. Diabet Med 1992, 9:144-149
61. Schurek HJ, Neumann KH, Jesinghaus WP, Aeikens B, Wonigeit K: Influence of cyclosporine A on adaptive hypertrophy after unilateral nephrectomy in the rat. Clin Nephrol 1986, 25(Suppl 1):S144-S147 (Pubitemid 16114298)
62. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982, 307:652-659 (Pubitemid 12049914)
63. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 1985, 249:F324-F337
64. Terasaki PI, Koyama H, Cecka JM, Gjertson DW: The hyperfiltration hypothesis in human renal transplantation. Transplantation 1994, 57: 1450-1454 (Pubitemid 24169941)
65. Sola R, Paredes D, Antonijoan RM, Estorch M, Vila LP, Guirado LL, Diaz JM, Gich I, Barbanoj MJ: Glomerular hyperfiltration, intrarenal hemodynamics, and chronic allograft nephropathy: physiopathology of chronic allograft nephropathy. Transplant Proc 2002, 34:340-342 (Pubitemid 34311699)
66. Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, Rose CH, Gavrilova L, Craigo P, Bailey KR, Achenbach J, Schiffer M, Grande JP: Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007, 196:320 e321-e327
67. Kretzler M: Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech 2002, 57: 247-253
68. Trusolino L, Cavassa S, Angelini P, Ando M, Bertotti A, Comoglio PM, Boccaccio C: HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J 2000, 14:1629-1640 (Pubitemid 30636566)
69. Skoberne A, Konieczny A, Schiffer M: Glomerular epithelial cells in the urine: what has to be done to make them worthwhile?. Am J Physiol Renal Physiol 2009, 296:F230-F241
70. Eremina V, Baelde HJ, Quaggin SE: Role of the VEGF - a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007, 106:32-37
71. Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE: Vascular endothelial growth factor A signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 2006, 17:724-735
72. Eremina V, Quaggin SE: The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 2004, 13:9-15 (Pubitemid 39069893)
73. Schumacher VA, Jeruschke S, Eitner F, Becker JU, Pitschke G, Ince Y, Miner JH, Leuschner I, Engers R, Everding AS, Bulla M, Royer-Pokora B: Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome. J Am Soc Nephrol 2007, 18:719-729 (Pubitemid 46434489)
74. Florquin S, Rouschop KM: Reciprocal functions of hepatocyte growth factor and transforming growth factor-beta1 in the progression of renal diseases: a role for CD44? Kidney Int Suppl 2003, S15-S20
75. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992, 360:361-364 (Pubitemid 23000677)
76. Sato M, Markiewicz M, Yamanaka M, Bielawska A, Mao C, Obeid LM, Hannun YA, Trojanowska M: Modulation of transforming growth factor-beta (TGF-beta) signaling by endogenous sphingolipid mediators. J Biol Chem 2003, 278:9276-9282 (Pubitemid 36800411)
77. Gaciong Z, Koziak K, Religa P, Lisiecka A, Morzycka-Michalik M, Rell K, Kozlowska-Boszko B, Lao M: Increased expression of growth factors during chronic rejection of human kidney allograft. Transplant Proc 1995, 27:928-929
78. Shihab FS, Yamamoto T, Nast CC, Cohen AH, Noble NA, Gold LI, Border WA: Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 1995, 6:286-294
79. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB: Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002, 13:779-787 (Pubitemid 34183946)
80. Palomar R, Lopez-Hoyos M, Pastor JM, Fernandez-Fresnedo G, Rodrigo E, Ruiz JC, Cotorruelo JG, Valero R, Castaneda O, San Segundo D, Arias M: Impact of HLA antibodies on transplant glomerulopathy. Transplant Proc 2005, 37:3830-3832 (Pubitemid 43015182)
81. Rampino T, Gregorini M, Camussi G, Conaldi PG, Soccio G, Maggio M, Bottelli A, Dal Canton A: Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis. Nephrol Dial Transplant 2005, 20:1066-1074 (Pubitemid 40862094)
82. Kusumoto K, Ido A, Moriuchi A, Katsura T, Kim I, Takahama Y, Numata M, Kodama M, Hasuike S, Nagata K, Uto H, Inui K, Tsubouchi H: Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Int J Mol Med 2006, 17:503-509
83. Takano Y, Yamauchi K, Hiramatsu N, Kasai A, Hayakawa K, Yokouchi M, Yao J, Kitamura M: Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin. Am J Physiol Renal Physiol 2007, 292:F1573-F1582 (Pubitemid 46701885)
84. Goldstein D, Leavitt J: Expression of neoplasia-related proteins of chemically transformed HuT fibroblasts in human osteosarcoma HOS fibroblasts and modulation of actin expression upon elevation of tumorigenic potential. Cancer Res 1985, 45:3256-3261 (Pubitemid 15007204)
85. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997, 16: 68-73 (Pubitemid 27198158)
86. Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, Nakamura T: Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998, 101:1827-1834 (Pubitemid 28226100)
87. Dworkin LD, Gong R, Tolbert E, Centracchio J, Yano N, Zanabli AR, Esparza A, Rifai A: Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney Int 2004, 65:409-419 (Pubitemid 38130635)
88. Yazawa K, Isaka Y, Takahara S, Imai E, Ichimaru N, Shi Y, Namba Y, Okuyama A: Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats. Nephrol Dial Transplant 2004, 19:812-816 (Pubitemid 38455650)
89. Mizui M, Isaka Y, Takabatake Y, Mizuno S, Nakamura T, Ito T, Imai E, Hori M: Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity. Kidney Int 2004, 65:2041-2053 (Pubitemid 38669990)
90. Azuma H, Takahara S, Matsumoto K, Ichimaru N, Wang JD, Moriyama T, Waaga AM, Kitamura M, Otsuki Y, Okuyama A, Katsuoka Y, Chandraker A, Sayegh MH, Nakamura T: Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 2001, 12:1280-1292 (Pubitemid 32472643)
91. Herrero-Fresneda I, Torras J, Franquesa M, Vidal A, Cruzado JM, Lloberas N, Fillat C, Grinyo JM: HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int 2006, 70:265-274 (Pubitemid 44086576)